| The peptidomimetic CXCR4 antagonist TC14012 recruits β-arrestin to CXCR7: Roles of receptor domains S Gravel, C Malouf, PE Boulais, YA Berchiche, S Oishi, N Fujii, R Leduc, ... Journal of biological chemistry 285 (49), 37939-37943, 2010 | 103 | 2010 |
| Molecular processes involved in B cell acute lymphoblastic leukaemia C Malouf, K Ottersbach Cellular and molecular life sciences 75, 417-446, 2018 | 92 | 2018 |
| Mll-AF4 confers enhanced self-renewal and lymphoid potential during a restricted window in development NA Barrett, C Malouf, C Kapeni, WA Bacon, G Giotopoulos, ... Cell reports 16 (4), 1039-1054, 2016 | 48 | 2016 |
| miR-130b and miR-128a are essential lineage-specific codrivers of t (4; 11) MLL-AF4 acute leukemia C Malouf, ETB Antunes, M O’Dwyer, H Jakobczyk, F Sahm, SL Landua, ... Blood, The Journal of the American Society of Hematology 138 (21), 2066-2092, 2021 | 26 | 2021 |
| The fetal liver lymphoid-primed multipotent progenitor provides the prerequisites for the initiation of t (4; 11) MLL-AF4 infant leukemia C Malouf, K Ottersbach Haematologica 103 (12), e571, 2018 | 24 | 2018 |
| DNA damage signalling from the placenta to foetal blood as a potential mechanism for childhood leukaemia initiation E Mansell, N Zareian, C Malouf, C Kapeni, N Brown, C Badie, D Baird, ... Scientific Reports 9 (1), 4370, 2019 | 12 | 2019 |
| Defining the fetal origin of MLL-AF4 infant leukemia highlights specific fatty acid requirements V Symeonidou, H Jakobczyk, S Bashanfer, C Malouf, F Fotopoulou, ... Cell reports 37 (4), 2021 | 11 | 2021 |
| Fetal liver Mll-AF4+ hematopoietic stem and progenitor cells respond directly to poly (I: C), but not to a single maternal immune activation C Malouf, K Ottersbach Experimental hematology 76, 49-59, 2019 | 5 | 2019 |
| Translational research for bone marrow failure patients C Malouf, SJ Loughran, AC Wilkinson, A Shimamura, P Río Experimental hematology 105, 18-21, 2022 | 4 | 2022 |
| p57Kip2 regulates embryonic blood stem cells by controlling sympathoadrenal progenitor expansion C Kapeni, L Nitsche, AM Kilpatrick, NK Wilson, K Xia, ... Blood, The Journal of the American Society of Hematology 140 (5), 464-477, 2022 | 3 | 2022 |
| Chronic inflammation can transform the fate of normal and mutant haematopoietic stem cells J Li, C Malouf, LA Miles, MB Willis, EM Pietras, KY King Experimental Hematology, 2023 | 2 | 2023 |
| Novel transcriptional targets of ETV6, a transcription factor frequently altered in childhood pre-B acute lymphoblastic leukemia C Malouf, K Lagace, C Drullion, S Langlois, J Larose, EA Kritikou, ... Cancer Sci Open Res Access 3 (1), 1-11, 2016 | 1 | 2016 |
| The unconventional embryo: immune-restricted potential precedes multipotentiality C Malouf, K Ottersbach Cell Stem Cell 13 (5), 509-510, 2013 | 1 | 2013 |
| Leukaemia in the CNS niche regulates PI3K/Akt signalling via upregulation of miR-93 in MLL-AF4+ infant leukaemia A Duguid, C Malouf, C Halsey, K Ottersbach Klinische Pädiatrie 235 (03), 0013, 2023 | | 2023 |
| Exploiting somatic mutations to decipher human blood production: a natural lineage-tracing strategy M Bloom, C Malouf, A Rodriguez-Fraticelli, AC Wilkinson, VG Sankaran, ... Experimental Hematology 121, 2-5, 2023 | | 2023 |
| A microRNA expression signature in infant t (4; 11) MLL-AF4+ BCP-ALL uncovers novel therapeutic targets C Malouf, A Duguid, G Camiolo, L Nitsche, H Jakobczyk, RS Kotecha, ... bioRxiv, 2023.01. 12.523775, 2023 | | 2023 |
| Leukaemia and the CNS Niche: Insights on Bidirectional Communication from a Model of Infant Leukaemia A Duguid, C Malouf, V Symeonidou, C Halsey, K Ottersbach Blood 140 (Supplement 1), 3038-3039, 2022 | | 2022 |
| Novel therapeutic avenues for MLL-AF4+ pro-B ALL patients based on a unique microRNA expression signature C Malouf, A Duguid, K Ottersbach Klinische Pädiatrie 234 (03), 0006, 2022 | | 2022 |
| 3105–IMPACT OF DACH1 DOWNREGULATION ON MLL-AF4 INFANT LEUKEMOGENESIS H Jakobczyk, G Camiolo, C Malouf, E Antunes, K Ottersbach Experimental Hematology 111, S97, 2022 | | 2022 |
| 3008–EXPLOITING THE UNIQUE MICRORNA EXPRESSION SIGNATURE OF MLL-AF4+ PRO-B ALL FOR NOVEL THERAPEUTIC AVENUES C Malouf, A Duguid, C Halsey, K Ottersbach Experimental Hematology 111, S48, 2022 | | 2022 |
